Positron emission tomography/computed tomography rather than conventional CT scanning should be used to image and assess follicular lymphoma, concludes a study in The Lancet Haematology.
An analysis of outcomes data found that there is little to no support for new joint replacements in comparison to their predecessors.
Medtronic unveiled a new study over the weekend indicating its transcatheter aortic valve replacement device provides "exceptional rates of survival" for patients two years after they received its CoreValve System implant because they were considered too high risk for traditional open-heart surgery.
Abbott released one-year data of the first randomized controlled trial of 501 patients, comparing its clinical-stage Absorb Bioresorbable Vascular Scaffold to the company's counterpart, the Xience drug-eluting stent, yesterday at the Transcatheter Cardiovascular Therapeutics conference in Washington, DC.
Researchers from the Nebraska Center for Materials and Nanoscience at the University of Nebraska have created a thin electronic skin made of nanoparticles and polymers that can be applied to the breast and used to find and image lumps.
The Defense Advanced Research Projects Agency awarded Harvard University engineers up to $2.9 billion to develop a robotic suit to make walking easier for soldiers and potentially civilians with disabilities, the university announced today.
Scripps Health has launched a pilot study of AirStrip One, a software system that delivers hospital patient-monitoring data to physicians' mobile devices. The 60-day pilot study, which is slated to end in early October, is intended to evaluate the potential for broader adoption.
Data from a study on a new nondrug treatment for chronic obstructive pulmonary disease offered evidence that Trudell Medical's Aerobika OPEP hand-held device is beneficial for COPD patients with recurring mucus buildup.
A study by American Medical Systems, a unit of Endo Health Solutions, showed that the company's fecal incontinence implant product reduced by half the number of weekly bowel leakage incidents in nearly 70% of the female participants.
Endoscopic surgery isn't usually associated with diabetes, but Fractyl Laboratories yesterday announced encouraging clinical trial results for its endoscopic procedure to treat Type 2 diabetes and revealed a $40 million Series C financing round led by investment firm Mithril Capital Management.